This article discusses the process of isolating phosphopeptides from cancer tissue, which are crucial for understanding cellular signaling pathways and identifying potential cancer biomarkers. The methodology involves using specific antibodies conjugated to hydrogel beads to capture phosphorylated peptides.
Phosphorylation of specific amino acid residues, like tyrosine, generates phosphopeptides that play critical roles in regulating several cellular signaling pathways. Studying them allows the identification of potential biomarkers for cancer therapy.
To isolate phosphopeptides, begin with a lyophilized powder of purified peptide digests extracted from cancer tissue. Resuspend the powder in a suitable buffer to prepare a uniform peptide suspension. Maintain a neutral pH to ensure peptide stability.
Prepare a slurry consisting of hydrogel beads conjugated to specific anti-phosphopeptide antibodies in the desired buffer. Add the bead slurry to the peptide suspension. The antibodies immobilized on the beads recognize and bind to their specific phosphorylated amino acid residues within the phosphopeptides, forming complexes.
Centrifuge the mixture to collect the phosphopeptide-bead complexes in the pellet. Remove the supernatant containing unbound peptides or non-specific phosphopeptides. Add a suitable low pH elution buffer to the complexes and incubate. The low pH weakens the interaction between the phosphopeptide residues and antibody-bead complexes, releasing the peptides into the solution.
Transfer the mixture to a pre-assembled filter cartridge. Centrifuge to elute the released phosphopeptides into the collection tube. Vacuum concentrate the sample at an elevated temperature to remove the buffer and obtain a concentrated dry pellet of pure phosphopeptides.
Resuspend the lyophilized powder with 0.5 milliliters of ice-cold immunoprecipitation, or IP, binding buffer in each fraction. Transfer the 0.5 milliliter resuspension volume from the second fraction to the tube with the first fraction and save the pipette tip. Use another 0.5 milliliters of IP buffer to rinse each lyophilization tube before transferring the contents to the cryotube. Then, repeat the rinse using 2 milliliters of IP buffer.
After using P200 with a cut tip to transfer the 0.5 milligrams per milliliter stock of antibody bead slurry to the microfuge tube, add 450 microliters of ice-cold IP binding buffer to wash 50 microliters of 4G10 antibody bead slurry and 25 microliters of 27B10.4 antibody bead slurry in a microfuge tube. Centrifuge the tube at 100 x g and 4 degrees Celsius for 1 minute. After aspirating the supernatant, add an equal volume as the original slurry of IP binding buffer to resuspend the beads. Add pre-washed pY beads to the resuspended sample solution in the screw cap cryotubes. Then, incubate them at 4 degrees Celsius on an end-over-end rotator overnight. After spinning down the beads, save the supernatant, which will be used to enrich for pST peptides.
Next, use 300 microliters of IP binding buffer to resuspend the beads and transfer them to a 2-milliliter microcentrifuge tube. Spin down the samples at 100 x g and 4 degrees Celsius for 1 minute. Then, with 500 microliters of IP binding buffer, wash the beads three times. Wash the beads four times with 450 microliters of 25 mM ammonium bicarbonate, pH 7.5. Dip a gel-loading tip slightly below the bead surface and completely aspirate the supernatant. Add four times the bead volume of 0.1% TFA to the beads.
Then, mix them well and incubate the tube in a thermomixer at 1,000 rpm and 37 degrees Celsius for 15 minutes. Transfer the resuspension to a 0.2-micrometer spin filter, and centrifuge the filter at 850 x g for 1 minute. After transferring the elution to a low protein-binding microcentrifuge tube, vacuum concentrate the eluate to dryness at 40 degrees Celsius with a heat time of 300 minutes overnight.
繁體中文
